Stock Research for BCRX

BCRX

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BCRX Stock Chart & Research Data

The BCRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BCRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BCRX Due diligence Resources & Stock Charts

The BCRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BCRX Detailed Price Forecast - CNN Money CNN View BCRX Detailed Summary - Google Finance
Yahoo View BCRX Detailed Summary - Yahoo! Finance Zacks View BCRX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View BCRX Trends & Analysis - Trade-Ideas Barrons View BCRX Major Holders - Barrons
NASDAQ View BCRX Call Transcripts - NASDAQ Seeking View BCRX Breaking News & Analysis - Seeking Alpha
Spotlight View BCRX Annual Report - CompanySpotlight.com OTC Report View BCRX OTC Short Report - OTCShortReport.com
TradeKing View BCRX Fundamentals - TradeKing Charts View BCRX SEC Filings - Bar Chart
WSJ View Historical Prices for BCRX - The WSJ Morningstar View Performance/Total Return for BCRX - Morningstar
MarketWatch View the Analyst Estimates for BCRX - MarketWatch CNBC View the Earnings History for BCRX - CNBC
StockMarketWatch View the BCRX Earnings - StockMarketWatch MacroAxis View BCRX Buy or Sell Recommendations - MacroAxis
Bullish View the BCRX Bullish Patterns - American Bulls Short Pains View BCRX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View BCRX Stock Mentions - StockTwits PennyStocks View BCRX Stock Mentions - PennyStockTweets
Twitter View BCRX Stock Mentions - Twitter Invest Hub View BCRX Investment Forum News - Investor Hub
Yahoo View BCRX Stock Mentions - Yahoo! Message Board Seeking Alpha View BCRX Stock Mentions - Seeking Alpha






Financial & Transaction Holdings

SECform4 View Insider Transactions for BCRX - SECform4.com Insider Cow View Insider Transactions for BCRX - Insider Cow
CNBC View BCRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BCRX - OTC Markets
Yahoo View Insider Transactions for BCRX - Yahoo! Finance NASDAQ View Institutional Holdings for BCRX - NASDAQ


Stock Charts

FinViz View BCRX Stock Insight & Charts - FinViz.com StockCharts View BCRX Investment Charts - StockCharts.com
BarChart View BCRX Stock Overview & Charts - BarChart Trading View View BCRX User Generated Charts - Trading View


Latest Financial News for BCRX

Great Point Partners, LLC Remains Opposed To The BioCryst Pharmaceutical Proposed Merger With Idera Pharmaceuticals, Inc.
Posted on Wednesday June 20, 2018

GREENWICH, Conn. , June 20, 2018 /PRNewswire/ -- Great Point Partners, LLC ("GPP") today submitted a letter to the Board of Directors of BioCryst Pharmaceuticals, Inc. ("BCRX") expressing ...


Idera Stock Down, Study on Dermatomyositis Candidate Fails
Posted on Wednesday June 13, 2018

Shares of Idera (IDRA) decline following the failure of a phase II study of its pipeline candidate, IMO-8400, on adult patients with dermatomyositis.


BioCryst Pharmaceuticals and Idera Pharmaceuticals to Present at the JMP Securities Life Sciences Conference
Posted on Wednesday June 13, 2018

RESEARCH TRIANGLE PARK, N.C. and EXTON, Pa., June 13, 2018-- BioCryst Pharmaceuticals, Inc., and Idera Pharmaceuticals, Inc., today announced that they will be presenting at the JMP Securities Life Sciences ...


BioCryst Issues Letter to Stockholders Reiterating Upside Potential of Value-Enhancing Merger with Idera
Posted on Tuesday June 05, 2018

BioCryst Pharmaceuticals, Inc. (BCRX) (“BioCryst” or the “Company”), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, today issued an open letter to stockholders in connection with the Company’s Special Meeting of Stockholders to be held on July 10, 2018. BioCryst’s Special Meeting of Stockholders is scheduled for July 10, 2018. The BioCryst Board of Directors believes this transaction represents a significant opportunity to enhance the value of your investment in BioCryst and unanimously recommends that stockholders vote “FOR” the transaction, which will create a new company to be called Valenscion Incorporated (“Valenscion” or the “combined company”).


Enter a stock symbol to view the stock details.